Dirk Reyn

Dirk Reyn

Dirk Reyn

Managing Partner - BioQube Ventures

Dirk Reyn is a Pharmacist and MBA'er with International Marketing, Global Sales Management, Product Development, Crisis Management, Business Development and General Management/biotech CEO skills acquired in the international pharmaceutical industry over a period of more than 38 years in both big and small companies and in different continents. 

He was a key player in at least 6 major pharma licensing and M&A deals in his capacity as head of BD for Europe while working for JNJ. After his tenure in big pharma (Lilly and JNJ), he was start-up CEO and founder of different companies including Movetis (2006), a public (Euronext) biopharmaceutical spin-off company from Janssen Pharmaceutica that was acquired by Shire, Progress Pharma (2012) that worked on a GI asset (Lipid, Heidelberg) before it was acquired by Nestle, eTheRNA (2015), a mRNA technology spin-off from the Free University of Brussels, and Spectricity (2018), an Imec spin-off with the smallest spectrometer on the planet.  He currently is one of the three Managing Partners of the Bioqube Factory Fund (2020), a specialized biotech investment Fund with 110 million under management. He is also President of flanders.bio, the organization of biotech companies in Flanders.

 

Registrations are now open!

KNOWLEDGE FOR GROWTH Institutional Partners

KNOWLEDGE FOR GROWTH Supporting Partners

FLANDERS.BIO Strategic Partners